Synedica BPC-157 & TB-500 40mg Pen – Dual Peptide Research Blend

The Synedica BPC-157 & TB-500 40mg Pen is a prefilled dual-peptide formulation developed for laboratory and investigational applications. This device combines BPC-157 and TB-500 in a stabilised solution, offering a controlled and convenient format for research protocols.

Each pen contains a total of 40mg peptide content, formulated in a 30% BPC-157 and 70% TB-500 ratio. The prefilled delivery system eliminates the need for reconstitution while maintaining compound integrity and consistent dosing.

Key Features

• 40mg total peptide content per pen
• BPC-157 (30%) and TB-500 (70%) combination
• Prefilled pen with 4 x 10mg dosing system
• No reconstitution required
• Stabilised formulation for compound integrity
• Designed for subcutaneous research administration
• Manufactured by Synedica

How to Use

• Attach a compatible sterile needle before each use
• Prime the pen if required according to instructions
• Select the required dose based on research protocol
• Administer via subcutaneous route where applicable
• Store refrigerated between 2–8°C

How It Works

• BPC-157 is studied in experimental repair models
• TB-500 is researched for cellular activity and recovery environments
• The dual-peptide combination allows broader investigational pathways

Recommended Research Pairings

• May be included in regeneration-focused studies
• Often investigated alongside metabolic or peptide protocols
• Can complement broader laboratory research frameworks